Macrophage KARAP Blockade Boosts IL-10 and Barrier Repair in Ulcerative Colitis
· newswise.com · popularity 17/100 · 0 similar stories today · Beauty, Skincare & Grooming (Fashion, Beauty & Luxury)
Read the original at newswise.com →
Summary
<img src="https://www.newswise.com/legacy/image.php?image=https://media.newswise.com/pio/articles/857869/6ae978f583186_Snipaste_2026-11-03_13-49-42_857869.jpg&width=100&height=150" alt="Newswise image" />Researchers have identified KARAP (killer cell activating receptor-associated protein), the protein product of the TYROBP gene, as a macrophage-centered regulator that may shape ulcerative colitis (UC) severity. In patient samples, TYROBP expression was elevated in macrophages and tracked with disease activity markers. In mice, deleting Tyrobp reduced dextran sulfate sodium (DSS)-induced colitis, preserved tight junctions, and strengthened the intestinal barrier. Mechanistically, loss of KARAP improved macrophage mitochondrial homeostasis through mechanistic target of rapamycin (mTOR)/mitophagy signaling, increased interleukin-10 (IL-10) production, and protected epithelial cells. The work positions KARAP as a candidate target for strategies that aim to restore mucosal repair rather than merely suppress inflammation. These findings link an immune adaptor to metabolic control of barrier protection.
Found in: Newswise. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 15.